Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Finasteride affects hair growth by changing caspase and XIAP levels, potentially treating hair diseases.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Thread-embedding therapy helped hair grow back in mice and might do the same in humans.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Juniperus plants contain compounds with potential for developing various medical treatments.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Mast cells might contribute to hair loss by causing skin thickening.

Human hair follicles can regenerate and recover after severe injury by going through a brief abnormal resting phase before growing again.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

XEDAR triggers a specific signaling pathway in cells.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Glycerin in hand cream can cause allergic skin reactions.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.